10,563
Views
5
CrossRef citations to date
0
Altmetric
Review Articles

The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential

ORCID Icon, , , , , , ORCID Icon & ORCID Icon show all
Pages 151-176 | Received 04 Aug 2021, Accepted 07 Feb 2022, Published online: 11 Mar 2022

References

  • Aakko J, Kumar H, Rautava S, Wise A, Autran C, Bode L, Isolauri E, Salminen S. 2017. Human milk oligosaccharide categories define the microbiota composition in human colostrum. Benef Microbes. 8(4):563–567.
  • Aatsinki AK, Keskitalo A, Laitinen V, Munukka E, Uusitupa HM, Lahti L, Kortesluoma S, Mustonen P, Rodrigues AJ, Coimbra B, et al. 2020. Maternal prenatal psychological distress and hair cortisol levels associate with infant fecal microbiota composition at 2.5 months of age. Psychoneuroendocrinology. 119(5):104754.
  • Addolorato G, Ponziani FR, Dionisi T, Mosoni C, Vassallo GA, Sestito L, Petito V, Picca A, Marzetti E, Tarli C, et al. 2020. Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease. Liver Int. 40(4):878–888.
  • Al-Ghezi ZZ, Busbee PB, Alghetaa H, Nagarkatti PS, Nagarkatti M. 2019. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. Brain Behav Immun. 82:25–35.
  • Alberdi A, Andersen SB, Limborg MT, Dunn RR, Gilbert MTP. 2021. Disentangling host-microbiota complexity through hologenomics. Nat Rev Genet. doi:10.1038/s41576-021-00421-0
  • Anderson JR, Carroll I, Azcarate-Peril MA, Rochette AD, Heinberg LJ, Peat C, Steffen K, Manderino LM, Mitchell J, Gunstad J. 2017. A preliminary examination of gut microbiota, sleep, and cognitive flexibility in healthy older adults. Sleep Med. 38:104–107.
  • Anhê FF, Nachbar RT, Varin TV, Vilela V, Dudonné S, Pilon G, Fournier M, Lecours MA, Desjardins Y, Roy D, et al. 2017. A polyphenol-rich cranberry extract reverses insulin resistance and hepatic steatosis independently of body weight loss. Mol Metab. 6(12):1563–1573.
  • Badal VD, Vaccariello ED, Murray ER, Yu KE, Knight R, Jeste DV, Nguyen TT. 2020. The gut microbiome, aging, and longevity: a systematic review. Nutrients. 12(12):3759.
  • Baldini F, Hertel J, Sandt E, Thinnes CC, Neuberger-Castillo L, Pavelka L, Betsou F, Kruger R, Thiele I, Consortium N-P. 2020. Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions. BMC Biol. 18(1):62.
  • Bana B, Cabreiro F. 2019. The Microbiome and Aging. Annu Rev Genet. 53:239–261.
  • Bárcena C, Valdés-Mas R, Mayoral P, Garabaya C, Durand S, Rodríguez F, Fernández-García MT, Salazar N, Nogacka AM, Garatachea N, et al. 2019. Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice. Nat Med. 25(8):1234–1242.
  • Barichella M, Severgnini M, Cilia R, Cassani E, Bolliri C, Caronni S, Ferri V, Cancello R, Ceccarani C, Faierman S, et al. 2019. Unraveling gut microbiota in Parkinson’s disease and atypical parkinsonism. Mov Disord. 34(3):396–405.
  • Basolo A, Hohenadel M, Ang QY, Piaggi P, Heinitz S, Walter M, Walter P, Parrington S, Trinidad DD, Von Schwartzenberg RJ, et al. 2020. Effects of underfeeding and oral vancomycin on gut microbiome and nutrient absorption in humans. Nat Med. 26(4):589–598.
  • Baxter NT, Zackular JP, Chen GY, Schloss PD. 2014. Structure of the gut microbiome following colonization with human feces determines colonic tumor burden. Microbiome. 2:20.
  • Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, Bork P, Wullner U. 2017. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients. Genome Med. 9(1):39.
  • Belzer C, De Vos WM. 2012. Microbes inside-from diversity to function: the case of Akkermansia. Isme J. 6(8):1449–1458.
  • Berer K, Gerdes LA, Cekanaviciute E, Jia X, Xiao L, Xia Z, Liu C, Klotz L, Stauffer U, Baranzini SE, et al. 2017. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Natl Acad Sci USA. 114(40):10719–10724.
  • Biagi E, Franceschi C, Rampelli S, Severgnini M, Ostan R, Turroni S, Consolandi C, Quercia S, Scurti M, Monti D, et al. 2016. Gut microbiota and extreme longevity. Curr Biol. 26(11):1480–1485.
  • Bian X, Wu W, Yang L, Lv L, Wang Q, Li Y, Ye J, Fang D, Wu J, Jiang X, et al. 2019. Administration of Akkermansia muciniphila ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. Front Microbiol. 10:2259.
  • Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, Kleimeyer C, Moresi C, Harnik Y, Zur M, et al. 2019. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 572(7770):474–480.
  • Bressa C, Bailén-Andrino M, Pérez-Santiago J, González-Soltero R, Pérez M, Montalvo-Lominchar MG, Maté-Muñoz JL, Domínguez R, Moreno D, Larrosa M. 2017. Differences in gut microbiota profile between women with active lifestyle and sedentary women. PLoS One. 12(2):e0171352.
  • Bulgart HR, Neczypor EW, Wold LE, Mackos AR. 2020. Microbial involvement in Alzheimer disease development and progression. Mol Neurodegener. 15(1):42.
  • Burokas A, Arboleya S, Moloney RD, Peterson VL, Murphy K, Clarke G, Stanton C, Dinan TG, Cryan JF. 2017. Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol Psychiatry. 82(7):472–487.
  • Carmody RN, Gerber GK, Luevano JM, Jr., Gatti DM, Somes L, Svenson KL, Turnbaugh PJ. 2015. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe. 17(1):72–84.
  • Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA, Kanner R, Bencosme Y, Lee YK, Hauser SL, et al. 2017. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci USA. 114(40):10713–10718.
  • Cerro ED, Lambea M, Félix J, Salazar N, Gueimonde M, De La Fuente M. 2021. Daily ingestion of Akkermansia mucciniphila for one month promotes healthy aging and increases lifespan in old female mice. Biogerontology. 2021:43.
  • Chaidez V, Hansen RL, Hertz-Picciotto I. 2014. Gastrointestinal problems in children with autism, developmental delays or typical development. J Autism Dev Disord. 44(5):1117–1127.
  • Chang Y, Woo HG, Jeong JH, Kim GH, Park KD, Song TJ. 2021. Microbiota dysbiosis and functional outcome in acute ischemic stroke patients. Sci Rep. 11(1):10977.
  • Chelakkot C, Choi Y, Kim DK, Park HT, Ghim J, Kwon Y, Jeon J, Kim MS, Jee YK, Gho YS, et al. 2018. Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp Mol Med. 50(2):e450.
  • Chen R, Wu P, Cai Z, Fang Y, Zhou H, Lasanajak Y, Tang L, Ye L, Hou C, Zhao J. 2019. Puerariae Lobatae Radix with chuanxiong Rhizoma for treatment of cerebral ischemic stroke by remodeling gut microbiota to regulate the brain-gut barriers. J Nutr Biochem. 65:101–114.
  • Chen Y, Fang L, Chen S, Zhou H, Fan Y, Lin L, Li J, Xu J, Chen Y, Ma Y, et al. 2020. Gut microbiome alterations precede cerebral amyloidosis and microglial pathology in a mouse model of Alzheimer’s Disease. Biomed Res Int. 2020:8456596.
  • Chu C, Murdock MH, Jing D, Won TH, Chung H, Kressel AM, Tsaava T, Addorisio ME, Putzel GG, Zhou L, et al. 2019. The microbiota regulate neuronal function and fear extinction learning.
  • Collado MC, Derrien M, Isolauri E, De Vos WM, Salminen S. 2007. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl Environ Microbiol. 73(23):7767–7770.
  • Collado MC, Laitinen K Fau- Salminen S, Salminen S, Fau- Isolauri E, Isolauri E. 2012. Maternal weight and excessive weight gain during pregnancy modify the immunomodulatory potential of breast milk.
  • Cox LM, Maghzi AH, Liu S, Tankou SK, Dhang FH, Willocq V, Song A, Wasen C, Tauhid S, Chu R, et al. 2021. The gut microbiome in progressive multiple sclerosis. Ann Neurol. 89(6):1195–1211.
  • Cox LM, Yamanishi S, Sohn J, Alekseyenko AV, Leung JM, Cho I, Kim SG, Li H, Gao Z, Mahana D, et al. 2014. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 158(4):705–721.
  • Cryan JF, Dinan TG. 2012. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 13(10):701–712.
  • Davidson GL, Cooke AC, Johnson CN, Quinn JL. 2018. The gut microbiome as a driver of individual variation in cognition and functional behaviour. Philos Trans R Soc Lond B Biol Sci. 2018:373.
  • De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, Guerzoni ME, Gobbetti M, Francavilla R. 2013. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 8(10):e76993.
  • De La Cuesta-Zuluaga J, Mueller NT, Corrales-Agudelo V, Velásquez-Mejía EP, Carmona JA, Abad JM, Escobar JS. 2017. Metformin is associated with higher relative abundance of mucin-degrading akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut. Diabetes Care. 40(1):54–62.
  • Demirci M, Tokman HB, Uysal HK, Demiryas S, Karakullukcu A, Saribas S, Cokugras H, Kocazeybek BS. 2019. Reduced Akkermansia muciniphila and Faecalibacterium prausnitzii levels in the gut microbiota of children with allergic asthma. Allergol Immunopathol. 47(4):365–371.
  • Derosa L, Routy B, Thomas AM, Iebba V, Zalcman G, Friard S, Mazieres J, Audigier-Valette C, Moro-Sibilot D, Goldwasser F, et al. 2022. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. Nat Med. 28(2):315–324. doi:10.1038/s41591-021-01655-5.
  • Derrien M, Collado MC, Ben-Amor K, Salminen S, De Vos WM. 2008. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl Environ Microbiol. 74(5):1646–1648.
  • Derrien M, Vaughan EE, Plugge CM, De Vos WM. 2004. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 54(Pt 5):1469–1476.
  • Ding Y, Bu F, Chen T, Shi G, Yuan X, Feng Z, Duan Z, Wang R, Zhang S, Wang Q, et al. 2021. A next-generation probiotic: Akkermansia muciniphila ameliorates chronic stress-induced depressive-like behavior in mice by regulating gut microbiota and metabolites. Appl Microbiol Biotechnol. 105(21–22):8411–8426.
  • Dodiya HB, Forsyth CB, Voigt RM, Engen PA, Patel J, Shaikh M, Green SJ, Naqib A, Roy A, Kordower JH, et al. 2020. Chronic stress-induced gut dysfunction exacerbates Parkinson’s disease phenotype and pathology in a rotenone-induced mouse model of Parkinson’s disease. Neurobiol Dis. 135:104352.
  • Doifode T, Giridharan VV, Generoso JS, Bhatti G, Collodel A, Schulz PE, Forlenza OV, Barichello T. 2021. The impact of the microbiota-gut-brain axis on Alzheimer’s disease pathophysiology. Pharmacol Res. 164:105314.
  • Dooling SW, Costa-Mattioli M. 2018. Gut bacteria seize control of the brain to prevent epilepsy. Cell Host Microbe. 24(1):3–5.
  • Drucker DJ. 2001. Glucagon-like peptide 2. J Clin Endocrinol Metab. 86(4):1759–1764.
  • Earley H, Lennon G, Balfe Á, Coffey JC, Winter DC, O'connell PR. 2019. The abundance of Akkermansia muciniphila and its relationship with sulphated colonic mucins in health and ulcerative colitis. Sci Rep. 9(1):15683.
  • Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, et al. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA. 110(22):9066–9071.
  • Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Neyrinck AM, Possemiers S, Van Holle A, Francois P, De Vos WM, et al. 2011. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes. 60(11):2775–2786.
  • Fåk F, Jakobsdottir G, Kulcinskaja E, Marungruang N, Matziouridou C, Nilsson U, Stålbrand H, Nyman M. 2015. The physico-chemical properties of dietary fibre determine metabolic responses, short-chain Fatty Acid profiles and gut microbiota composition in rats fed low- and high-fat diets. PLoS One. 10(5):e0127252.
  • Fang X, Zhou X, Miao Y, Han Y, Wei J, Chen T-O. 2020. Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer’s disease and Parkinson’s disease.
  • Farr SA, Roesler E, Niehoff ML, Roby DA, Mckee A, Morley JE. 2019. Metformin Improves Learning and Memory in the SAMP8 Mouse Model of Alzheimer’s Disease. J Alzheimers Dis. 68(4):1699–1710.
  • Finegold SM. 2008. Therapy and epidemiology of autism-clostridial spores as key elements. Med Hypotheses. 70(3):508–511.
  • Finegold SM. 2011. State of the art; microbiology in health and disease. Intestinal bacterial flora in autism. Anaerobe. 17(6):367–368.
  • Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, Youn E, Summanen PH, Granpeesheh D, Dixon D, et al. 2010. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe. 16(4):444–453.
  • Foster JA, Mcvey Neufeld KA. 2013. Gut-brain axis: How the microbiome influences anxiety and depression. Trends Neurosci. 36(5):305–312.
  • Fransen F, Van Beek AA, Borghuis T, Aidy SE, Hugenholtz F, Van Der Gaast-De Jongh C, Savelkoul HFJ, De Jonge MI, Boekschoten MV, Smidt H, et al. 2017. Aged gut microbiota contributes to systemical inflammaging after transfer to germ-free mice. Front Immunol. 8:1385.
  • Ganesh BP, Klopfleisch R, Loh G, Blaut M. 2013. Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella typhimurium-infected gnotobiotic mice. PLoS One. 8(9):e74963.
  • Geerlings SY, Kostopoulos I, De Vos WM, Belzer C. 2018. Akkermansia muciniphila in the human gastrointestinal tract: When, where, and how? Microorganisms. 6(3):75.
  • Gorecki AM, Preskey L, Bakeberg MC, Kenna JE, Gildenhuys C, Macdougall G, Dunlop SA, Mastaglia FL, Akkari PA, Koengten F, et al. 2019. Altered gut microbiome in Parkinson’s Disease and the influence of lipopolysaccharide in a human α-synuclein over-expressing mouse model. Front Neurosci. 13:839.
  • Goswami C, Iwasaki Y, Yada T. 2018. Short-chain fatty acids suppress food intake by activating vagal afferent neurons. J Nutr Biochem. 57:130–135.
  • Gotkine M, Kviatcovsky D, Elinav E. 2020. Amyotrophic lateral sclerosis and intestinal microbiota-toward establishing cause and effect. Gut Microbes. 11(6):1833–1841.
  • Grander C, Adolph TE, Wieser V, Lowe P, Wrzosek L, Gyongyosi B, Ward DV, Grabherr F, Gerner RR, Pfister A, et al. 2018. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut. 67(5):891–901.
  • Gu Z, Pei W, Shen Y, Wang L, Zhu J, Zhang Y, Fan S, Wu Q, Li L, Zhang Z. 2021. Akkermansia muciniphila and its outer protein Amuc_1100 regulates tryptophan metabolism in colitis. Food Funct. 12(20):10184–10195.
  • Guevara-Cruz M, Flores-López AG, Aguilar-López M, Sánchez-Tapia M, Medina-Vera I, Díaz D, Tovar AR, Torres N. 2019. Improvement of lipoprotein profile and metabolic endotoxemia by a lifestyle intervention that modifies the gut microbiota in subjects with metabolic syndrome. J Am Heart Assoc. 8(17):e012401.
  • Guo X, Zhang J, Wu F, Zhang M, Yi M, Peng Y. 2016. Different subtype strains of Akkermansia muciniphila abundantly colonize in southern China. J Appl Microbiol. 120(2):452–459.
  • Hanninen A, Toivonen R, Poysti S, Belzer C, Plovier H, Ouwerkerk JP, Emani R, Cani PD, De Vos WM. 2018. Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice. Gut. 67(8):1445–1453.
  • Hansen CH, Krych L, Nielsen DS, Vogensen FK, Hansen LH, Sørensen SJ, Buschard K, Hansen AK. 2012. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia. 55(8):2285–2294.
  • Heintz-Buschart A, Pandey U, Wicke T, Sixel-Doring F, Janzen A, Sittig-Wiegand E, Trenkwalder C, Oertel WH, Mollenhauer B, Wilmes P. 2018. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder. Mov Disord. 33(1):88–98.
  • Higarza SG, Arboleya S, Arias JL, Gueimonde M, Arias N. 2021. Akkermansia muciniphila and environmental enrichment reverse cognitive impairment associated with high-fat high-cholesterol consumption in rats. Gut Microbes. 13(1):1–20.
  • Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA, Molho E, Zabetian CP, et al. 2017. Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome. Mov Disord. 32(5):739–749.
  • Hou YF, Shan C, Zhuang SY, Zhuang QQ, Ghosh A, Zhu KC, Kong XK, Wang SM, Gong YL, Yang YY, et al. 2021. Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease. Microbiome. 9(1):34.
  • Huang C, Li Y, Feng X, Li D, Li X, Ouyang Q, Dai W, Wu G, Zhou Q, Wang P, et al. 2019. Distinct gut microbiota composition and functional category in children with cerebral palsy and epilepsy. Front Pediatr. 7:394.
  • Huck O, Mulhall H, Rubin G, Kizelnik Z, Iyer R, Perpich JD, Haque N, Cani PD, De Vos WM, Amar S. 2020. Akkermansia muciniphila reduces Porphyromonas gingivalis-induced inflammation and periodontal bone destruction. J Clin Periodontol. 47(2):202–212.
  • Inoue R, Sakaue Y, Sawai C, Sawai T, Ozeki M, Romero-Perez GA, Tsukahara T. 2016. A preliminary investigation on the relationship between gut microbiota and gene expressions in peripheral mononuclear cells of infants with autism spectrum disorders. Biosci Biotechnol Biochem. 80(12):2450–2458.
  • Jackson PA, Reay JL, Scholey AB, Kennedy DO. 2012. DHA-rich oil modulates the cerebral haemodynamic response to cognitive tasks in healthy young adults: a near IR spectroscopy pilot study. Br J Nutr. 107(8):1093–1098.
  • Jangi S, Gandhi R, Cox LM, Li N, Von Glehn F, Yan R, Patel B, Mazzola MA, Liu S, Glanz BL, et al. 2016. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 7:12015.
  • Jeon H, Bae CH, Lee Y, Kim HY, Kim S. 2021. Korean red ginseng suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced inflammation in the substantia nigra and colon. Brain Behav Immun. 94:410–423.
  • Ji S, Wang L, Li L. 2019. Effect of metformin on short-term high-fat diet-induced weight gain and anxiety-like behavior and the gut microbiota. Front Endocrinol. 10:704.
  • Jiang C, Li G, Huang P, Liu Z, Zhao B. 2017. The gut microbiota and Alzheimer’s Disease. J Alzheimers Dis. 58(1):1–15.
  • Joseph J, Depp C, Shih PB, Cadenhead KS, Schmid-Schönbein G. 2017. Modified mediterranean diet for enrichment of short chain fatty acids: potential adjunctive therapeutic to target immune and metabolic dysfunction in schizophrenia? Front Neurosci. 11:155.
  • Kang CS, Ban M, Choi EJ, Moon HG, Jeon JS, Kim DK, Park SK, Jeon SG, Roh TY, Myung SJ, et al. 2013a. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS One. 8(10):e76520.
  • Kang DW, Park JG, Ilhan ZE, Wallstrom G, Labaer J, Adams JB, Krajmalnik-Brown R. 2013b. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One. 8(7):e68322.
  • Karlsson CL, Onnerfalt J, Xu J, Molin G, Ahrne S, Thorngren-Jerneck K. 2012. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity. 20(11):2257–2261.
  • Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM. 2015. Colonic bacterial composition in Parkinson’s disease. Mov Disord. 30(10):1351–1360.
  • Kim BS, Choi CW, Shin H, Jin SP, Bae JS, Han M, Seo EY, Chun J, Chung JH. 2019. Comparison of the gut microbiota of centenarians in longevity villages of South Korea with those of other age groups. J Microbiol Biotechnol. 29(3):429–440.
  • Kong F, Hua Y, Zeng B, Ning R, Li Y, Zhao J. 2016. Gut microbiota signatures of longevity. Curr Biol. 26(18):R832–r833.
  • Lee Y, Park JY, Lee EH, Yang J, Jeong BR, Kim YK, Seoh JY, Lee S, Han PL, Kim EJ. 2017. Rapid assessment of microbiota changes in individuals with autism spectrum disorder using bacteria-derived membrane vesicles in urine. Exp Neurobiol. 26(5):307–317.
  • Li C, Cui L, Yang Y, Miao J, Zhao X, Zhang J, Cui G, Zhang Y. 2019a. Gut microbiota differs between Parkinson’s disease patients and healthy controls in Northeast China. Front Mol Neurosci. 12:171.
  • Li N, Wang X, Sun C, Wu X, Lu M, Si Y, Ye X, Wang T, Yu X, Zhao X, et al. 2019b. Change of intestinal microbiota in cerebral ischemic stroke patients. BMC Microbiol. 19(1):191.
  • Lin A, Zheng W, He Y, Tang W, Wei X, He R, Huang W, Su Y, Huang Y, Zhou H, et al. 2018. Gut microbiota in patients with Parkinson’s disease in Southern China. Parkinsonism Relat Disord. 53:82–88.
  • Lin CH, Chen CC, Chiang HL, Liou JM, Chang CM, Lu TP, Chuang EY, Tai YC, Cheng C, Lin HY, et al. 2019. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease. J Neuroinflammation. 16(1):129.
  • Liu Z, Liu HY, Zhou H, Zhan Q, Lai W, Zeng Q, Ren H, Xu D. 2017. Moderate-intensity exercise affects gut microbiome composition and influences cardiac function in myocardial infarction mice. Front Microbiol. 8:1687.
  • Lowe PP, Gyongyosi B, Satishchandran A, Iracheta-Vellve A, Ambade A, Kodys K, Catalano D, Ward DV, Szabo G. 2017. Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice. PLoS One. 12(3):e0174544.
  • Lu XY, Huang S, Chen QB, Zhang D, Li W, Ao R, Leung FC, Zhang Z, Huang J, Tang Y, et al. 2020. Metformin ameliorates Aβ pathology by insulin-degrading enzyme in a transgenic mouse model of Alzheimer’s Disease. Oxid Med Cell Longev. 2020:2315106.
  • Lukovac S, Belzer C, Pellis L, Keijser BJ, De Vos Wm Fau- Montijn RC, Montijn RC, Roeselers G. 2014. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. LID. 5(4):14.
  • Luna E, Luk KC. 2015. Bent out of shape: α-synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease. FEBS Lett. 589(24 Pt A):3749–3759.
  • Lv WJ, Liu C, Yu LZ, Zhou JH, Li Y, Xiong Y, Guo A, Chao LM, Qu Q, Wei GW, et al. 2020. Melatonin alleviates neuroinflammation and metabolic disorder in DSS-induced depression rats. Oxid Med Cell Longev. 2020:1241894.
  • Ma D, Wang AC, Parikh I, Green SJ, Hoffman JD, Chlipala G, Murphy MP, Sokola BS, Bauer B, Hartz AMS, et al. 2018. Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice. Sci Rep. 8(1):6670.
  • Manderino L, Carroll I, Azcarate-Peril MA, Rochette A, Heinberg L, Peat C, Steffen K, Mitchell J, Gunstad J. 2017. Preliminary evidence for an association between the composition of the gut microbiome and cognitive function in neurologically healthy older adults. J Int Neuropsychol Soc. 23(8):700–705.
  • Mcgaughey KD, Yilmaz-Swenson T, Elsayed NM, Cruz DA, Rodriguiz RM, Kritzer MD, Peterchev A, A OX, Roach J, Wetsel WC, et al. 2019. Relative abundance of Akkermansia spp. and other bacterial phylotypes correlates with anxiety- and depressive-like behavior following social defeat in mice.
  • Meckel KR, Kiraly DD. 2019. A potential role for the gut microbiome in substance use disorders. Psychopharmacology (Berl). 236(5):1513–1530.
  • Meireles M, Rodríguez-Alcalá LM, Marques C, Norberto S, Freitas J, Fernandes I, Mateus N, Gomes A, Faria A, Calhau C. 2016. Effect of chronic consumption of blackberry extract on high-fat induced obesity in rats and its correlation with metabolic and brain outcomes. Food Funct. 7(1):127–139.
  • Nagpal R, Neth BJ, Wang S, Craft S, Yadav H. 2019. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer’s disease markers in subjects with mild cognitive impairment. EBioMedicine. 47:529–542.
  • Naito Y, Uchiyama K, Takagi T. 2018. A next-generation beneficial microbe: akkermansia muciniphila. J Clin Biochem Nutr. 63(1):33–35.
  • Neth BJ, Mintz A, Whitlow C, Jung Y, Solingapuram Sai K, Register TC, Kellar D, Lockhart SN, Hoscheidt S, Maldjian J, et al. 2020. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer’s disease: a pilot study. Neurobiol Aging. 86:54–63.
  • Newell C, Bomhof MR, Reimer RA, Hittel DS, Rho JM, Shearer J. 2016. Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder. Mol Autism. 7:37.
  • Nichols RG, Davenport ER. 2021. The relationship between the gut microbiome and host gene expression: a review. Hum Genet. 140(5):747–760.
  • Nishiwaki H, Ito M, Ishida T, Hamaguchi T, Maeda T, Kashihara K, Tsuboi Y, Ueyama J, Shimamura T, Mori H, et al. 2020. Meta-analysis of gut dysbiosis in Parkinson’s Disease. Mov Disord. 35(9):1626–1635.
  • Nobel YR, Cox LM, Kirigin FF, Bokulich NA, Yamanishi S, Teitler I, Chung J, Sohn J, Barber CM, Goldfarb DS, et al. 2015. Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment. Nat Commun. 6:7486.
  • Olson CA, Vuong HE, Yano JM, Liang QY, Nusbaum DJ, Hsiao EY. 2018. The gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell. 173(7):1728–1741 e1713.
  • Ottman N, Geerlings SY, Aalvink S, De Vos WM, Belzer C. 2017a. Action and function of Akkermansia muciniphila in microbiome ecology, health and disease. Best Pract Res Clin Gastroenterol. 31(6):637–642.
  • Ottman N, Reunanen J, Meijerink M, Pietila TE, Kainulainen V, Klievink J, Huuskonen L, Aalvink S, Skurnik M, Boeren S, et al. 2017b. Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. PLoS One. 12(3):e0173004.
  • Ottman NA. 2015. Host immunostimulation and substrate utilization of the gut symbiont Akkermansia muciniphila.
  • Ou Z, Deng L, Lu Z, Wu F, Liu W, Huang D, Peng Y-O. 2020. Protective effects of Akkermansia muciniphila on cognitive deficits and amyloid pathology in a mouse model of Alzheimer's disease. Nutr Diabetes.10(1).
  • Ou Z, Kong X, Sun X, He X, Zhang L, Gong Z, Huang J, Xu B, Long D, Li J, et al. 2018. Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice. Brain Behav Immun. 69:351–363.
  • Park S, Cho SM, Jin BR, Yang HJ, Yi QJ. 2019. Mixture of blackberry leaf and fruit extracts alleviates non-alcoholic steatosis, enhances intestinal integrity, and increases Lactobacillus and Akkermansia in rats. Exp Biol Med. 244(18):1629–1641.
  • Park YS, Kim SH, Park JW, Kho Y, Seok PR, Shin JH, Choi YJ, Jun JH, Jung HC, Kim EK. 2020. Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation. Intest Res. 18(3):325–336.
  • Pietrucci D, Cerroni R, Unida V, Farcomeni A, Pierantozzi M, Mercuri NB, Biocca S, Stefani A, Desideri A. 2019. Dysbiosis of gut microbiota in a selected population of Parkinson’s patients. Parkinsonism Relat Disord. 65:124–130.
  • Pietrucci D, Teofani A, Unida V, Cerroni R, Biocca S, Stefani A, Desideri A. 2020. Can gut microbiota be a good predictor for Parkinson’s Disease? A machine learning approach. Brain Sci. 10(4):242.
  • Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L, Chilloux J, Ottman N, Duparc T, Lichtenstein L, et al. 2016. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 23(1):107–113.
  • Png CW, Lindén SK, Gilshenan KS, Zoetendal EG, Mcsweeney CS, Sly LI, Mcguckin MA, Florin TH. 2010. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 105(11):2420–2428.
  • Rabe-Jabłońska J, Bieńkiewicz W. 1994. Anxiety disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association: diagnostic and statistical manual of mental disorders (DMS-IV – options book. Psychiatr Pol. 28(2):255–268.
  • Reunanen J, Kainulainen V, Huuskonen L, Ottman N, Belzer C, Huhtinen H, De Vos WM, Satokari R. 2015. Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer. Appl Environ Microbiol. 81(11):3655–3662.
  • Rodakis J. 2015. An n = 1 case report of a child with autism improving on antibiotics and a father’s quest to understand what it may mean. Microb Ecol Health Dis. 26:26382.
  • Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A. 2021. Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis. 7(1):27.
  • Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, et al. 2018. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors. Science. 359(6371):91–97. doi:10.1126/science.aan3706.
  • Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Väisänen ML, Nelson MN, Wexler HM. 2000. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol. 15(7):429–435.
  • Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, et al. 2015. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord. 30(3):350–358.
  • Seregin SS, Golovchenko N, Schaf B, Chen J, Pudlo NA, Mitchell J, Baxter NT, Zhao L, Schloss PD, Martens EC, et al. 2017. NLRP6 protects Il10–/– mice from colitis by limiting colonization of akkermansia muciniphila. Cell Rep. 19(4):733–745.
  • Sharon G, Cruz NJ, Kang DW, Gandal MJ, Wang B, Kim YM, Zink EM, Casey CP, Taylor BC, Lane CJ, et al. 2019. Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice. Cell. 177(6):1600–1618.
  • Shen T, Yue Y, He T, Huang C, Qu B, Lv W, Lai HY. 2021. The association between the gut microbiota and Parkinson’s disease, a meta-analysis. Front Aging Neurosci. 13:636545.
  • Shin J, Noh JR, Choe D, Lee N, Song Y, Cho S, Kang EJ, Go MJ, Ha SK, Chang DH, et al. 2021. Ageing and rejuvenation models reveal changes in key microbial communities associated with healthy ageing. Microbiome. 9(1):240.
  • Shin NR, Lee JC, Lee HY, Kim MS, Whon TW, Lee MS, Bae JW. 2014. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut. 63(5):727–735.
  • Shukla D, Maheshwari RA, Patel K, Balaraman R, Sen AK. 2018. Effect of Vaccinium macrocarpon on MK-801-induced psychosis in mice. Indian J Pharmacol. 50(5):227–235.
  • Singh H, Torralba MG, Moncera KJ, Dilello L, Petrini J, Nelson KE, Pieper R. 2019. Gastro-intestinal and oral microbiome signatures associated with healthy aging. Geroscience. 41(6):907–921.
  • Song J, Ma W, Gu X, Zhao L, Jiang J, Xu Y, Zhang L, Zhou M-O, Yang L. 2019. Metabolomic signatures and microbial community profiling of depressive rat model induced by adrenocorticotrophic hormone. J Transl Med. 17(1):1–12.
  • Stanley D, Moore RJ, Wong CHY. 2018. An insight into intestinal mucosal microbiota disruption after stroke. Sci Rep. 8(1):568.
  • Strati F, Cavalieri D, Albanese D, De Felice C, Donati C, Hayek J, Jousson O, Leoncini S, Renzi D, Calabro A, et al. 2017. New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome. 5(1):24.
  • Swidsinski A, Dörffel Y, Loening-Baucke V, Theissig F, Rückert JC, Ismail M, Rau WA, Gaschler D, Weizenegger M, Kühn S, et al. 2011. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut. 60(1):34–40.
  • Syal C, Kosaraju J, Hamilton L, Aumont A, Chu A, Sarma SN, Thomas J, Seegobin M, Dilworth FJ, He L, et al. 2020. Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease. Theranostics. 10(14):6337–6360.
  • Teixeira TFS, Grześkowiak ŁM, Salminen S, Laitinen K, Bressan J, Gouveia Peluzio MdC. 2013. Faecal levels of Bifidobacterium and Clostridium coccoides but not plasma lipopolysaccharide are inversely related to insulin and HOMA index in women. Clin Nutr. 32(6):1017–1022.
  • Tan J, Mckenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. 2014. The role of short-chain fatty acids in health and disease. Adv Immunol. 121:91–119.
  • Tankou SK, Regev K, Healy BC, Tjon E, Laghi L, Cox LM, Kivisakk P, Pierre IV, Hrishikesh L, Gandhi R, et al. 2018. A probiotic modulates the microbiome and immunity in multiple sclerosis. Ann Neurol. 83(6):1147–1161.
  • Tung TH, Tung YT, Lin IH, Shih CK, Nguyen NTK, Shabrina A, Huang SY. 2019. Fish oil, but not olive oil, ameliorates depressive-like behavior and gut microbiota dysbiosis in rats under chronic mild stress. Biomolecules. 9(10):516.
  • Unger MM, Spiegel J, Dillmann K-U, Grundmann D, Philippeit H, Bürmann J, Faßbender K, Schwiertz A, Schäfer K-H. 2016. Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls. Parkinsonism Relat Disord. 32:66–72.
  • Van Der Lugt B, Van Beek AA, Aalvink S, Meijer B, Sovran B, Vermeij WP, Brandt RMC, De Vos WM, Savelkoul HFJ, Steegenga WT, et al. 2019. Akkermansia muciniphila ameliorates the age-related decline in colonic mucus thickness and attenuates immune activation in accelerated aging Ercc1-/Δ7 mice. Immun Ageing. 16:6–17.
  • Van Herreweghen F, Van Den Abbeele P, De Mulder T, De Weirdt R, Geirnaert A, Hernandez-Sanabria E, Vilchez-Vargas R, Jauregui R, Pieper DH, Belzer C, et al. 2017. In vitro colonisation of the distal colon by Akkermansia muciniphila is largely mucin and pH dependent. Benef Microbes. 8(1):81–96.
  • Vidal-Martinez G, Chin B, Camarillo C, Herrera GV, Yang B, Sarosiek I, Perez RG. 2020. A pilot microbiota study in Parkinson’s Disease patients versus control subjects, and effects of FTY720 and FTY720-mitoxy therapies in parkinsonian and multiple system atrophy mouse models. J Parkinsons Dis. 10(1):185–192.
  • Vitale M, Giacco R, Laiola M, Della Pepa G, Luongo D, Mangione A, Salamone D, Vitaglione P, Ercolini D, Rivellese AA. 2021. Acute and chronic improvement in postprandial glucose metabolism by a diet resembling the traditional Mediterranean dietary pattern: can SCFAs play a role? Clin Nutr. 40(2):428–437.
  • Wakabayashi K, Takahashi H, Ohama E, Ikuta F. 1990. Parkinson’s disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol. 79(6):581–583.
  • Waldecker M, Kautenburger T, Daumann H, Busch C, Schrenk D. 2008. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem. 19(9):587–593.
  • Wallen ZD, Appah M, Dean MN, Sesler CL, Factor SA, Molho E, Zabetian CP, Standaert DG, Payami H. 2020. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. NPJ Parkinsons Dis. 6:11.
  • Wang J, Xu W, Wang R, Cheng R, Tang Z, Zhang M. 2021. The outer membrane protein Amuc_1100 of Akkermansia muciniphila promotes intestinal 5-HT biosynthesis and extracellular availability through TLR2 signalling. Food Funct. 12(8):3597–3610.
  • Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA. 2011. Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Appl Environ Microbiol. 77(18):6718–6721.
  • Wang L, Tang L, Feng Y, Zhao S, Han M, Zhang C, Yuan G, Zhu J, Cao S, Wu Q, et al. 2020a. A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice. Gut. 69(11):1988–1997.
  • Wang Y, Zhao J, Guo FL, Gao X, Xie X, Liu S, Yang X, Yang X, Zhang L, Ye Y, et al. 2020b. Metformin ameliorates synaptic defects in a mouse model of AD by inhibiting Cdk5 activity. Front Cell Neurosci. 14:170.
  • Wong ML, Inserra A, Lewis MD, Mastronardi CA, Leong L, Choo J, A O, Kentish S, Xie P, Morrison M, et al. 2016. Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry. 21(6):797–805.
  • Wu CY, Ouk M, Wong YY, Anita NZ, Edwards JD, Yang P, Shah BR, Herrmann N, Lanctôt KL, Kapral MK, et al. 2020a. Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer’s disease, and the role APOE carrier status. Alzheimers Dement. 16(12):1663–1673.
  • Wu F, Guo X, Zhang M, Ou Z, Wu D, Deng L, Lu Z, Zhang J, Deng G, Chen S, et al. 2020b. An Akkermansia muciniphila subtype alleviates high-fat diet-induced metabolic disorders and inhibits the neurodegenerative process in mice. Anaerobe. 61:102138.
  • Wu W, Lv L, Shi D, Ye J, Fang D, Guo F, Li Y, He X, Li L. 2017. Protective effect of akkermansia muciniphila against immune-mediated liver injury in a mouse model. Front Microbiol. 8:1804.
  • Xiang L, Lou Y, Liu L, Liu Y, Zhang W, Deng J, Guan Y, She M, You X, Liu M, et al. 2020. Gut microbiotic features aiding the diagnosis of acute ischemic stroke. Front Cell Infect Microbiol. 10:587284.
  • Xu M, Xu X, Li J, Li F. 2019. Association between gut microbiota and autism spectrum disorder: a systematic review and meta-analysis. Front Psychiatry. 10:473.
  • Yan J, Sheng L, Li H. 2021. Akkermansia muciniphila: is it the Holy Grail for ameliorating metabolic diseases? Gut Microbes. 13(1):1984104.
  • Yang C, Fu X, Hao W, Xiang X, Liu T, Yang BZ, Zhang X. 2020. Gut dysbiosis associated with the rats' responses in methamphetamine-induced conditioned place preference. Addict Biol. 2020:e12975.
  • Yang Y, Zhong Z, Wang B, Xia X, Yao W, Huang L, Wang Y, Ding W. 2019. Early-life high-fat diet-induced obesity programs hippocampal development and cognitive functions via regulation of gut commensal Akkermansia muciniphila. Neuropsychopharmacology. 44(12):2054–2064.
  • Ye F, Shen H, Li Z, Meng F, Li L, Yang J, Chen Y, Bo X, Zhang X, Ni M. 2016. Influence of the biliary system on biliary bacteria revealed by bacterial communities of the human biliary and upper digestive tracts. PLoS One. 11(3):e0150519.
  • Yoon HS, Cho CH, Yun MS, Jang SJ, You HJ, Kim JH, Han D, Cha KH, Moon SH, Lee K, et al. 2021. Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice. Nat Microbiol. 6(5):563–573.
  • Zhai Q, Feng S, Arjan N, Chen W. 2019a. A next generation probiotic, Akkermansia muciniphila. Crit Rev Food Sci Nutr. 59(19):3227–3236.
  • Zhai R, Xue X, Zhang L, Yang X, Zhao L, Zhang C. 2019b. Strain-specific anti-inflammatory properties of two Akkermansia muciniphila strains on chronic colitis in mice. Front Cell Infect Microbiol. 9:239.
  • Zhang H, Sparks JB, Karyala SV, Settlage R, Luo XM. 2015. Host adaptive immunity alters gut microbiota. Isme J. 9(3):770–781.
  • Zhang L, Meng J, Ban Y, Jalodia R, Chupikova I, Fernandez I, Brito N, Sharma U, Abreu MT, Ramakrishnan S, et al. 2019a. Morphine tolerance is attenuated in germfree mice and reversed by probiotics, implicating the role of gut microbiome. Proc Natl Acad Sci USA. 116(27):13523–13532.
  • Zhang T, Li Q, Cheng L, Buch H, Zhang F. 2019b. Akkermansia muciniphila is a promising probiotic. Microb Biotechnol. 12(6):1109–1125.
  • Zhang T, Li Q, Cheng L, Buch H, Zhang F-O. 2019c. Akkermansia muciniphila is a promising probiotic. Microb Biotechnol. 12(6):1109–1125.
  • Zou R, Xu F, Wang Y, Duan M, Guo M, Zhang Q, Zhao H, Zheng H. 2020. Changes in the gut microbiota of children with autism spectrum disorder. Autism Res. 13(9):1614–1625.